Impact of Behavioral Activation on Depression and Quality of Life in Patients with Colon Cancer

NCT ID: NCT06745700

Last Updated: 2024-12-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-31

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this randomized clinical trial is to study anxiety and depression symptoms at diagnosis in patients with colon cancer. Previous studies have shown that so-called. Behavioural activation as therapy for these symptoms has a positive impact on the patient's well-being, but it has not been studied whether it also has a positive impact on the patient's mental health in cancer, and whether it can have a prognostically beneficial effect on cancer recurrence risk and survival.

The investigators will investigate the prevalence of anxiety and depression symptoms as well as quality of life in colon cancer patients at diagnosis and at follow-up using self-estimated validated protocols in a prospective cohort study. Data will be compared with data from a reference population. In the cohort study the investigators will also perform a nested randomized clinical trial of a brief psychological treatment called Behavioural Activation to patients with colon cancer and comorbid anxiety and/or depression.

All participants will answer the questionnaires at diagnosis, after1, 2 and 6 months and after 1 and 3 years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Colon cancer is common. At diagnosis, about 20% have metastatic disease. The prognosis is determined by the stage of the tumour and the degree of spread, but also by the patient's physical health and other diseases. However, it is not known how the patient's mental health are affected and how common anxiety and depression symptoms are at diagnosis. Depression is known to be one of the most common causes of ill health in the world. It also has been shown that patients with depression and cancer also have a poorer survival rate compared to cancer patients without depression However, previous studies have shown that so-called brief Behavioural activation as therapy for these symptoms has a positive impact on the patient's well-being, but it has not been studied whether it also has a positive impact on the patient's mental health in cancer, and whether it can have a prognostically beneficial effect.

The goal of this randomized study is to increase knowledge about, to detect and treat anxiety and depression symptoms in patients with colon cancer, with so-called brief behavioural activation, which can lead to improved care, and possibly improve the patients' prognosis in the form of reduced risk of cancer recurrence and improved survival.

All participants will continue their care as usual (CAU), and half of the participants will be randomized to receive a five-session telephone-based BA-treatment spread over two months as an add-on to CAU. All participants will answer a questionnaire in the beginning of the study, 4 weeks after diagnosis, after 9 weeks, and after 3-, 6- and 12 months.

The main questions that the trial aims to answer are if the BA-treatment has an effect in the short and long term on:

* Depressive symptoms
* Anxiety symptoms
* Self-rated activation
* Self efficacy
* Mental wellbeing
* Quality of life
* Cancer recurrence and survival

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression - Major Depressive Disorder Anxiety Colon Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

depression anxiety health related quality of life colon cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Behavioral: Brief Behavioral Activation

A five-session telephone-based brief behavioral activation treatment.

Session 1: Psychoeducation about depression; treatment rationale for Behavioral Activation (BA); rationale and instructions for activity log.

Session 2: Discussion of life goals and values; planning of activities aligned with life goals and values for coming week.

Session 3-4: Troubleshooting any problems carrying out activities; planning activities aligned with life goals and values for coming week.

Session 5: Troubleshooting any problems carrying out activities; reviewing treatment; stressing the importance of continuing to engage in activities aligned. with life goals and values; creating a a maintenance plan.

Other group: care as usual.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Brief Behavioural Activation

Five-session Brief Behavioral Activation intervention. Sessions 1 - 4 are completed once a week, and session 5 is a booster-session completed four weeks after session 4 and care as usual provided by Region Västmanland.

Group Type EXPERIMENTAL

Brief Behavioural Activation

Intervention Type BEHAVIORAL

Behavioral: Brief Behavioral Activation.

A five-session telephone-based brief behavioral activation treatment.

Session 1: Psychoeducation about depression; treatment rationale for Behavioral Activation (BA); rationale and instructions for activity log.

Session 2: Discussion of life goals and values; planning of activities aligned with life goals and values for coming week.

Session 3-4: Troubleshooting any problems carrying out activities; planning activities aligned with life goals and values for coming week.

Session 5: Troubleshooting any problems carrying out activities; reviewing treatment; stressing the importance of continuing to engage in activities aligned. with life goals and values; creating a a maintenance plan.

Other group: care as usual.

Care as usual

Intervention Type OTHER

Care as usual provided by Region Västamanland,

Care as Usual

Care as usual provided by Västmanland County hospital.

Group Type OTHER

Care as usual

Intervention Type OTHER

Care as usual provided by Region Västamanland,

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Brief Behavioural Activation

Behavioral: Brief Behavioral Activation.

A five-session telephone-based brief behavioral activation treatment.

Session 1: Psychoeducation about depression; treatment rationale for Behavioral Activation (BA); rationale and instructions for activity log.

Session 2: Discussion of life goals and values; planning of activities aligned with life goals and values for coming week.

Session 3-4: Troubleshooting any problems carrying out activities; planning activities aligned with life goals and values for coming week.

Session 5: Troubleshooting any problems carrying out activities; reviewing treatment; stressing the importance of continuing to engage in activities aligned. with life goals and values; creating a a maintenance plan.

Other group: care as usual.

Intervention Type BEHAVIORAL

Care as usual

Care as usual provided by Region Västamanland,

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

* language difficulties that cause patients to be unable to absorb the treatment
* ongoing alcohol or substance use syndrome
* elevated suicide risk
* ongoing psychotic disorder, severe depression
* antidepressant treatment initiated within the last month
* ongoing or previous manic episode
* cognitive illness/dementia
* ongoing psychological treatment.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Region Västmanland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Catarina Tiselius

MD, PhD, Assoc. professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre for Clinical research and Dept. of Surgery

Västerås, Region Västmanland, Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Catarina Tiselius, MD, PhD, Ass. prof.

Role: CONTACT

Phone: +46707343826

Email: [email protected]

Johnny Pellas, PhD, psychologist

Role: CONTACT

Phone: 004621173000

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Fanny Johansen, MD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Pellas J, Renner F, Ji JL, Damberg M. Telephone-based behavioral activation with mental imagery for depression: A pilot randomized clinical trial in isolated older adults during the Covid-19 pandemic. Int J Geriatr Psychiatry. 2022 Jan;37(1):10.1002/gps.5646. doi: 10.1002/gps.5646. Epub 2021 Nov 10.

Reference Type BACKGROUND
PMID: 34729823 (View on PubMed)

Funderburk JS, Pigeon WR, Shepardson RL, Maisto SA. Brief behavioral activation intervention for depressive symptoms: Patient satisfaction, acceptability, engagement, and treatment response. Psychol Serv. 2020 Nov;17(4):443-451. doi: 10.1037/ser0000328. Epub 2019 Feb 4.

Reference Type BACKGROUND
PMID: 30714752 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LTV-1011976

Identifier Type: -

Identifier Source: org_study_id